MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Quantitative Keyboard Tapping Measurement Correlates with Electrophysiological Changes in STN LFPs of PD Patients Treated with L-dopa Better Than UPDRS Subscores

    M. Ozturk, A. Abosch, D. Francis, J. Wu, N. Ince (Houston, TX, USA)

    Objective: Reliable and objective assessment of the symptoms of patients with Parkinson’s disease (PD) and the correlation of the measures with neural patterns is important…
  • 2018 International Congress

    Saccades in Parkinson’s disease: Hypometric, slow, or maladaptive?

    L. Neilson, F. Ghasia, A. Shaikh (Cleveland, OH, USA)

    Objective: Quantitatively study visually-guided saccades (VGS) in Parkinson’s disease (PD). Background: Visuomotor deficits such as hypometric VGS are present in PD despite the retained ability…
  • 2018 International Congress

    Evaluation of Parkinson’s Disease Psychosis Requires Structured Questioning of Patients and Caregivers

    P. Schmidt, F. Cubillos, A. Diaz, P. Wiener, S. Metz, N. Romero, C. Andersson, S. Andes, D. Fredericks, A. Shim (Miami, FL, USA)

    Objective: To determine the relationship between the patient and caregiver experience of the psychotic features of Parkinson's disease psychosis (PDP) reported to call center healthcare…
  • 2018 International Congress

    What can we learn from fMRI capture of visual hallucinations in Parkinson’s disease?

    K. Dujardin, D. Roman, G. Baille, D. Pins, S. Lefebvre, C. Delmaire, L. Defebvre, R. Jardri (Lille, France)

    Objective: To describe the patterns of brain functional changes when visual hallucinations (VH) occur in patients with Parkinson's disease (PD). Background: ​With disease progression, PD…
  • 2018 International Congress

    A Psychometric Analysis of the MDS UPDRS-II and III in Early Parkinson’s disease: Do the Numbers Add Up?

    A. Regnault, B. Boroodjerdi, J. Meunier, M. Bani, S. Cano (Lyon, France)

    Objective: Our objective was to explore the psychometric evidence for the use of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part II…
  • 2018 International Congress

    Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD

    J. Málly (Sopron, Hungary)

    Objective: We hypothesized that the regularly repeated rTMS would decrease the development of PD and that there might be a synergistic effect with transcranial direct…
  • 2018 International Congress

    Feasibility and Efficacy of Brainstem Modulation Therapy for the Management of Parkinson’s Disease

    K. Ade, A. Podlewska, T. Pellet-Higgins, S. Banducci, M. Bodani, M. Sakel, D. Wilkinson (Raleigh, NC, USA)

    Objective: To evaluate the feasibility and potential efficacy of a software-controlled, solid-state caloric vestibular stimulation (CVS)-mediated brainstem modulation device for the treatment of non-motor and…
  • 2018 International Congress

    Levodopa effect on non-motor symptoms in late stage Parkinson’s disease

    K. Rosqvist, P. Odin, P. Hagell, S. Iwarsson, M. Nilsson, A. Storch (Lund, Sweden)

    Objective: To assess responsiveness of non-motor symptoms (NMS) to Levodopa (L-dopa) and to describe the NMS burden in late stage Parkinson's disease (PD). Moreover, to…
  • 2018 International Congress

    Effect of Viewpoint and Visual Texture on Object Recognition in Dementia with Lewy Bodies and in Alzheimer’s Disease

    Y. Oishi, K. Suzuki, T. Imamura, T. Shimomura (Niigata, Japan)

    Objective: To examine the effect of viewpoint and visual texture on visual object recognition in mild cognitive impairment (MCI) or dementia due to DLB or…
  • 2018 International Congress

    Levosulpiride Induced Movement Disorder: 7 cases

    D. Radhakrishnan, V. Goyal (New Delhi, India)

    Objective: Through this article we want to highlight extrapyramidal side effects of levosulpiride and need of its awareness among treating physicians. Background: Levosulpiride is a…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 177
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley